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Abstract 27 
Microalgae are regarded as promising organisms to develop innovative concepts based on 28 
their photosynthetic capacity that offers more sustainable production than heterotrophic 29 
hosts. However, to realize their potential as green cell factories, a major challenge is to make 30 
microalgae easier to engineer. A promising approach for rapid and predictable genetic 31 
manipulation is to use standardized synthetic biology tools and workflows. To this end we 32 
have developed a Modular Cloning toolkit for the green microalga Chlamydomonas 33 
reinhardtii. It is based on Golden Gate cloning with standard syntax, and comprises 119 34 
openly distributed genetic parts, most of which have been functionally validated in several 35 
strains. It contains promoters, UTRs, terminators, tags, reporters, antibiotic resistance genes, 36 
and introns cloned in various positions to allow maximum modularity. The toolkit enables 37 
rapid building of engineered cells for both fundamental research and algal biotechnology. 38 
This work will make Chlamydomonas the next chassis for sustainable synthetic biology. 39 
 40 
Keywords: Algal biotechnology, Chlamydomonas reinhardtii, modular cloning, synthetic 41 
biology. 42 
 43 
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There is an urgent need to decarbonize the world economy due to depletion of fossil fuel 45 
reserves coupled with accumulation of greenhouse gases produced by their combustion. 46 
One alternative to the use of fossil fuels is to use photosynthetic microorganisms, such as 47 
microalgae, as green cell factories to produce fuels and chemicals from atmospheric CO2 in a 48 
sustainable process driven by sunlight1, 2. The fixed carbon can be redirected towards 49 
compounds that can be used in the fuel, food, cosmetic and pharmaceutical industries, such 50 
as proteins, alcohols, alkanes, lipids, sugars, pigments or terpenes3-5. By contrast with land 51 
plant-based photoproduction, microalgae do not compete with agriculture and can be grown 52 
at high yields even at large scale
4, 6
, including on waste streams, thus minimizing inputs
3
. The 53 
green microalga Chlamydomonas reinhardtii (referred to hereafter as “Chlamydomonas”) 54 
has been extensively engineered for basic research and industrial biotechnology4, 6-8. Its 55 
nuclear and organellar genomes are sequenced and annotated, molecular biology 56 
techniques and culture conditions are highly developed, and its physiology and metabolism 57 
are well understood9-13. Moreover, the metabolic plasticity and cellular compartments of 58 
Chlamydomonas offer great potential for advanced metabolic engineering strategies14, 15. 59 
Chlamydomonas has already been engineered for production of the biodiesel precursor 60 
bisabolene8, the terpene patchoulol7, and recombinant proteins as well as enzymes such as 61 
an HIV antigen16 and xylanase17. Despite these proofs of concept however, engineering of 62 
Chlamydomonas is still slow due to a lack of standardized resources and tools11. 63 
Development of the field of algal synthetic biology offers the means to enable design and 64 
construction of microalgal cells with defined and predictable properties18. Besides 65 
biotechnological applications, the transition from empirical to synthetic approaches also 66 
provides the opportunity to answer fundamental biological questions using new concepts 67 
and approaches based on understanding by construction rather than deconstruction. 68 
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Synthetic biology approaches, predicated on the Design-Build-Test-Learn cycle19, make 69 
organisms easier to engineer through the use of standardized parts and their assembly to 70 
simplify the building of designed DNA molecules
19
. Among available standards
20
, the Golden 71 
Gate Modular Cloning (MoClo) technology, based on Type IIS restriction enzymes, offers 72 
extensive standardization and allows the assembly of complex multigenic DNA from basic 73 
gene parts (e.g. promoters, CDS, terminators) in just two steps
21, 22
. The method accelerates 74 
and multiplies the possibilities to permute multiple genetic elements, and makes facile the 75 
building of multigene constructs for full metabolic pathways23. MoClo is efficient and 76 
versatile, but relies on intensive upfront generation of a standardized library of basic 77 
building blocks, the gene parts, that have been domesticated to remove Type IIS sites, and 78 
codon optimized for the host as appropriate. MoClo toolkits have already been developed 79 
for a few model organisms
24-29
 although not yet for microalgae. 80 
Here, we report the generation of a MoClo toolkit composed of more than 100 gene parts 81 
codon-optimized for the Chlamydomonas nuclear genome. These genetic parts were 82 
designed to provide maximum modularity to end-users, and to facilitate the development of 83 
engineered strains for fundamental and green biotechnological applications, through 84 
iterative design and testing. We provide functional validation and characterization of many 85 
gene parts in several Chlamydomonas strains. This kit is available to the community, to allow 86 
Chlamydomonas to become the next chassis for sustainable synthetic biology approaches. 87 
RESULTS 88 
Standard and content of the Chlamydomonas MoClo kit 89 
Standardization is the key to efficient building. The Chlamydomonas MoClo kit adopts the 90 
syntax proposed by the plant synthetic biology community including the OpenPlant 91 
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Consortium30 (Fig. 1). This syntax is defined for level 0 plasmids containing standard gene 92 
parts (promoters, coding sequences, untranslated regions, etc.) and assigns strict fusion sites 93 
for 10 cloning positions. In a single step, standardized parts can be assembled into modules 94 
(Transcriptional Unit, TU, level 1) and modules into devices (multigenic construct, level M or 95 
2) according to the original MoClo syntax22 (Supplementary Fig. 1). Our Chlamydomonas 96 
MoClo toolkit is composed of a set of 119 parts representing 67 unique genetic elements 97 
available at different positions within the standard, thereby providing maximum modularity 98 
to designers (Fig. 1, Fig. 2). The kit recapitulates most of the standard genetic elements 99 
previously developed for Chlamydomonas which we “domesticated” by removing BpiI and 100 
BsaI restriction sites (the two enzymes used by the MoClo strategy22, Supplemental Figure 1) 101 
from their sequences by DNA synthesis or PCR-based mutagenesis. The available gene parts 102 
encompass 7 promoters coupled or not to their original 5’UTR, the corresponding 5’UTR and 103 
the CrTHI4 riboswitch, 8 immunological or purification tags in positions leading to N- or C-104 
terminal translational fusions, 9 signal and targeting peptides, 12 reporters, 5 antibiotic 105 
resistance genes, the foot and mouth virus (FMDV) 2A peptide which allows expression of 106 
two or more proteins from a single transcriptional unit17, 31, 32, 2 micro RNA (miRNA) 107 
backbones and associated controls, and six 3’UTR-terminators (Fig. 1b, Fig. 2 and 108 
Supplementary Table 1). All sequences and plasmids are available through the public 109 
Addgene repository (http://www.addgene.org/). 110 
Constitutive promoters and reporter genes 111 
Five antibiotic resistance genes are used as selectable markers for Chlamydomonas but also 112 
can function as reporter genes33, 34. We assembled three modules that allow control of the 113 
expression of the aadA gene, conferring spectinomycin resistance, by three constitutive 114 
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promoters: PPSAD and PβTUB2 with or without the first intron of βTUB2 (pCM1-1 to 3, 115 
Supplementary Table 3). The transformation efficiency of the three modules in UVM435 cells 116 
was estimated by counting spectinomycin resistant colonies and showed resistance 117 
frequencies within the same range (Fig. 3a). The presence of the first βTUB2 intron 118 
significantly increased the transformation efficiency as previously observed with the 119 
presence of RBCS2 introns in the ble marker33, 36, 37. Alternative reporters are bioluminescent 120 
proteins, which allow more sensitive and quantitative analysis of gene expression. The kit 121 
contains Gaussia princeps luciferase, the brightest luciferase established in 122 
Chlamydomonas38, as well as the redesigned Nanoluciferase (NanoLuc) which provides a 123 
stable and strong luminescence signal
39
. Chlamydomonas NanoLuc was specifically 124 
developed for our MoClo kit through recoding to match the codon bias of Chlamydomonas, 125 
and cloned at 6 different positions within the standard. This new part was first tested with 126 
the most widely used promoter/terminator combination (PAR promoter / TRBCS2 terminator) 127 
for strong constitutive expression in Chlamydomonas. The corresponding module (pCM1-04) 128 
was assembled with another module conferring paromomycin resistance (Supplementary 129 
Fig. 2) into a device (pCMM-1) that was introduced into the genome of the D66 strain (CC-130 
4425, Fig. 3b). Among paromomycin resistant colonies, 34.8% ± 8.3 (N=48, mean ± SEM) 131 
were luminescent. The signal was variable between clones due to genomic position effects40, 132 
41 but was linear from 50 to 5 x 105 cells (Fig. 3b and Supplementary Fig. 2). By contrast, non-133 
expressing transformants (resistant to paromomycin only) or the D66 recipient strain 134 
displayed only a faint signal, 3 orders of magnitude lower, and saturating swiftly (Fig. 3b, 135 
inset). The modularity of the MoClo strategy allows rapid assessment of combinations of 136 
multiple parts. For example, we assembled 4 modules where NanoLuc expression is 137 
controlled by all possible combinations of the two most common constitutive promoters (PAR 138 
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and PPSAD) and terminators (TRBCS2 and TPSAD) (Fig. 3b, pCM1-4 to 7, Supplementary Table 3). 139 
Each module was assembled with the paromomycin resistance module (pCMM-1 to 4, 140 
Supplementary Table 4) and introduced into the Chlamydomonas genome. Bioluminescence 141 
levels were averaged over hundreds of transformants to account for the genome position 142 
effect40, 41. The strengths of the two promoters were found to be comparable, whilst TPSAD 143 
appeared to confer robust expression from both promoters, 10-fold higher than TRBCS2 (Fig. 144 
3c). In a distinct context (strain, reporter sequence, culture conditions, etc.), the same 145 
genetic element may perform differently31, 35. Such context sensitivity can be overcome by 146 
taking advantage of the modularity of the Chlamydomonas MoClo kit, which allows for the 147 
rapid characterization of all possible parts combinations. These results also confirmed the 148 
performance of the Chlamydomonas NanoLuc reporter and its employability for detailed 149 
understanding and characterization of genetic circuits especially if coupled with automated 150 
cell-sorting microfluidic devices42. 151 
Control of gene expression 152 
To build genetic circuits, the fine-tuning of gene expression is a prerequisite. Multiple parts 153 
enabling controlled gene expression have therefore been implemented. The activity of the 154 
PNIT1 promoter can be controlled by switching the nitrogen source since it is strongly 155 
repressed by ammonium and highly induced on nitrate34, 43, 44. A module where PNIT1 controls 156 
expression of the ble-GFP gene (pCM1-8) conferred strong zeocin resistance in the CC-1690 157 
strain but only when ammonium was replaced by nitrate as nitrogen source. By contrast, the 158 
PPSAD promoter (pCM1-9) conferred strong antibiotic resistance on both nitrogen sources 159 
(Fig. 4a and Supplementary Fig. 3a-c). The vitamin B12-repressible promoter PMETE
45 allowed 160 
conditional functional complementation of the photosynthetic mutant nac2-26 (CC-4421), 161 
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which lacks photosystem II due to the absence of the TPR-like protein NAC2 required for 162 
stability of the psbD mRNA encoding the D2 reaction center protein46. nac2-26 mutant cells 163 
engineered with a module harboring the NAC2 coding sequence under the control of the 164 
PMETE promoter (pCM1-10) could grow photoautotrophically in the absence of vitamin B12, 165 
but growth was compromised by increasing its concentration by amounts as low as 5 ng/L 166 
(Fig. 4b). 167 
Regulation of gene expression can also be controlled by vitamin B1 (thiamine) at the level of 168 
the transcript through riboswitches47, 48. Binding of thiamine pyrophosphate to the THI4 169 
riboswitch (RS) results in alternative splicing and retention of an 81 bp upstream open 170 
reading frame, ultimately interfering with translation47, 48. The RS also responds when cells 171 
are grown in the presence of the thiamine biosynthetic intermediate 4-methyl-5-(2-172 
hydroxyethyl) thiazole (HET), but not with 4-amino-5-hydroxymethyl-2-methylpyrimidine 173 
(HMP)47. A module combining PAR and THI4 (RS) to drive expression of the ble-GFP gene 174 
(pCM1-11) conferred conditional zeocin sensitivity in the UVM4 strain35. Resistance was 175 
compromised by thiamine or HET but not HMP (Fig. 4c and Supplementary Fig. 3d), thereby 176 
demonstrating the efficient repression of the transgene through the THI4 riboswitch. 177 
Finally, to allow targeted repression of gene expression, a microRNA precursor sequence 178 
derived from the pre-miR1157 and used for the generation of artificial miRNAs (amiRNA)49 179 
was re-designed for compatibility with the Golden Gate cloning method. To demonstrate its 180 
effectiveness in driving gene repression, a specific amiRNA sequence directed against the 181 
MAA7 gene, whose repression provides resistance to 5'-fluoroindole (5’-FI)50, was inserted 182 
into the microRNA precursor. A control random sequence (“scrambled”) amiRNA was 183 
inserted into the same backbone. These parts were placed under the control of PPSAD and 184 
TPSAD (pCM1-12 and 13) and assembled with a paromomycin resistance module (pCM1-27). 185 
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The same amiRNA sequences were introduced into the previously established pChlamiRNA3 186 
vector49 as controls. After transformation of the CC-1690 strain, 36% of paromomycin-187 
resistant cells displayed resistance to 5’-FI with the device targeting MAA7 (pCMM-5) but 188 
not with the scrambled amiRNA (pCMM-6) (Fig. 4d and Supplementary Fig. 3f). A modified 5' 189 
rapid amplification of cDNA ends (5’-RACE) assay revealed that the MAA7 transcript was 190 
most frequently cleaved at a site corresponding to positions 10 and 11 of the amiRNA, as 191 
expected for a specific action of the miRNA (Fig. 4d). The properties of controllable parts can 192 
also be combined as shown for PNIT1 control of amiRNA-dependent gene repression
34. An 193 
amiRNA strategy recently proved useful for concerted metabolic engineering of a biodiesel 194 
precursor in Chlamydomonas8. The versatility of the MoClo kit opens new possibilities for 195 
sophisticated metabolic engineering strategies, e.g. the specific downregulation of up to six 196 
target genes with one level M assembly. 197 
Multiple fusion tags for detection and purification of gene products. 198 
Protein fusion tags are indispensable tools used to improve protein expression yields, enable 199 
protein purification, and accelerate the characterization of protein structure and function51. 200 
Our MoClo kit includes multiple epitope and affinity tags known to be functional in 201 
Chlamydomonas. The modularity of the MoClo assembly allows rapid assessment of the best 202 
tagging strategy through a rapid design/build/test/learn cycle. We took advantage of the 203 
well characterized rap2 mutant (∆FKBP12), which is insensitive to rapamycin52, to test the 204 
functionality of five tags (Fig. 5a,b). We designed and built 5 devices allowing strong 205 
constitutive expression of N- or C-terminal tagged FKBP12 coupled to a paromomycin 206 
module (pCMM-7 to 11, Fig. 5c-h and Supplementary Table 4). The engineered strains were 207 
selected on paromomycin and the functionality of the fusion protein was tested by assessing 208 
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sensitivity to rapamycin. Protein extracts were probed by immunoblotting using FKBP12-209 
specific and tag-specific antibodies (Fig. 5d-h). All tags allowed detection (Fig. 5d-h) or 210 
purification (Fig. 5i) of FKBP12 even though some were not functional for restoring 211 
rapamycin sensitivity. The test revealed that pCMM-9 outperforms other devices since it 212 
provides a WT-like phenotype and expression level coupled to a strong and specific Myc 213 
signal with no significant processing of the protein. These results demonstrate the 214 
importance of the modularity provided by the Chlamydomonas MoClo toolkit for designing 215 
optimal fusion proteins. 216 
Visualization and targeting of proteins in living cells 217 
Fluorescent protein tags allow the temporal and spatial monitoring of dynamic expression 218 
patterns at cellular and subcellular scales53. Natural and synthetic metabolic pathways can 219 
be optimized through spatial organization since cell compartments offer many advantages, 220 
such as isolation of metabolic reactions and generation of concentration gradients14. In a 221 
eukaryotic chassis like Chlamydomonas, organelles such as microbodies, mitochondria and 222 
chloroplasts can be engineered to implement or improve metabolic pathways15. The 223 
Chlamydomonas MoClo kit includes 11 targeting and signal peptides that allow the targeting 224 
of fusion proteins to mitochondria, chloroplast, nucleus, secretory pathway, ER and 225 
peroxisome-like microbodies. The functionality of the targeting and signal peptides and of 226 
the five fluorescent proteins (mVenus - yellow, mCherry - red, mRuby2 - red, Clover - green, 227 
mCerrulean3 - cyan) included in the toolkit was tested. Eight modules (pCM1-19 to 26, 228 
Supplementary Table 3) combining diverse fluorescent proteins and targeting sequences 229 
were assembled into devices with an antibiotic resistance module (pCMM-12 to 19). All 230 
devices were found to behave as expected and provided the expected fluorescent signal in 231 
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the targeted compartment (Fig. 6). The fluorescent and targeting parts of the 232 
Chlamydomonas MoClo toolkit, most of which have been validated here, enable engineering 233 
in the third dimension
14
 i.e. isolation and organization in multiple cellular compartments, 234 
and offer new tools for biological design/build/test cycles. 235 
Discussion 236 
The Chlamydomonas MoClo toolkit presented here provides more than 100 domesticated 237 
gene parts to allow advanced synthetic biology in microalgae. Numerous parts of multiple 238 
types have been characterized and validated in different genetic backgrounds10 and culture 239 
conditions, and can be readily used for biological design without further development. With 240 
the efficiency and modularity of the MoClo strategy, molecular cloning is no longer a limiting 241 
step for engineering Chlamydomonas cells. Indeed, from design to building, a complex 242 
device of up to six different genes/modules can be obtained within a week using the 243 
standardized parts provided in our kit. The modularity will also enable combinatorial 244 
assembly by shuffling part libraries54 and determine a posteriori which combination is the 245 
most relevant. The development of gene-editing technologies in Chlamydomonas, including 246 
Zinc-finger nucleases55, 56 and several CRISPR-Cas9 approaches55, 57-59, together with the 247 
development of high-throughput microfluidics42 are beginning to gather pace. Coupling 248 
these resources to our standardized MoClo toolkit will facilitate the use of Chlamydomonas 249 
as the photosynthetic chassis for innovative synthetic biology approaches aimed at 250 
fundamental and biotechnological applications. We expect that the creativity of designers, 251 
released from the time constraints associated with classical cloning strategies, will allow 252 
rapid expansion of the standard gene parts, modules and devices through open distribution, 253 
notably using the Addgene repository. We invite the community to openly share their parts 254 
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through Addgene and/or our consortium (contact M. Schroda). The development of the 255 
Chlamydomonas MoClo toolkit constitutes a complete step-change in the fields of microalgal 256 
biology and biotechnology. The parts developed for the MoClo toolkit may also be employed 257 
in other microalgal species since the orthogonality of several Chlamydomonas 258 
transcriptional units has been demonstrated in multiple hosts, including the industrially 259 
relevant species Chlorella ellipsoidea, Nannochloropsis sp. and Dunaliella salina
60
. Synthetic 260 
approaches will allow engineering of microalgae in a predictable and efficient manner and 261 
thereby offer great potential to couple environmental protection, energy transition and 262 
bioeconomic growth
4
.  263 
 264 
Methods 265 
All chemicals were obtained from Sigma-Aldrich, unless otherwise specified. 266 
 267 
Escherichia coli and Chlamydomonas reinhardtii strains, transformation and growth 268 
conditions.  269 
Bacterial growth was performed at 37°C in LB broth supplemented with agar (20% m/V), 270 
spectinomycin (50 μg/mL), ampicillin or carbenicillin (50 or 100 μg/mL, respectively) and X-271 
gal (40 µg/mL) when required. Chemically competent E. coli DH10β (New England Biolabs) 272 
were used for transformation (by heat shock following the manufacturer’s instructions) and 273 
maintenance of plasmids. All plasmids of the kit were maintained and amplified in TOP10 274 
E. coli strain prior to submission to Addgene. 275 
C. reinhardtii strains35, 46, 52, 61, 62, culture and transformation conditions are recapitulated in 276 
Supplementary Table 5. They were grown in Tris-Acetate-Phosphate (TAP) medium63 277 
supplemented with agar (1.6 % m/V), spectinomycin (100 µg/mL), paromomycin (15 µg/mL), 278 
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zeocin (ThermoFisher Scientific, 10 to 15 µg/mL), 5-fluoroindole (20 µM) or rapamycin (LC 279 
Laboratories, 1 µM) when required. For NIT1 promoter characterization (Figure 4a), a 280 
modified TAP medium lacking nitrogen source (TAP-N) was used instead, and was 281 
supplemented with 4 mM KNO3 (nitrate) or 7.5 mM NH4Cl (ammonium). For NAC2 282 
autotrophy test (Figure 4b), cells were grown in minimal media (HSM) for selection of 283 
complemented strains. The responsiveness to B12 was assessed on plate and then in liquid. 284 
Cells were grown for 15 days in HSM until 1-5 x107 cells/mL concentration prior to 285 
inoculation in a 96-well plate at a concentration of 105 cells/mL in 200 μL of HSM. For 286 
response assays (Figure 4c) thiamine (Melford Laboratories Ltd.), 4-methyl-5-(2-287 
hydroxyethyl) thiazole (HET) and 4-amino-5-hydroxymethyl-2-methylpyrimidine (HMP, 288 
Fluorochem UK) were added to TAP media at a final concentration of 10 µM.  289 
For transformation by electroporation (see Supplementary Table 5), a TAP culture of 1-5 x 290 
106 cells/mL was concentrated 100 times in TAP complemented with 60 mM sucrose or the 291 
MAX Efficiency Transformation reagent for Algae (ThermoFisher scientific) and 25-250 µL 292 
were incubated with 80-300 ng of DNA for 10-30 min on ice in a 0.4 cm gapped cuvette 293 
(BioRad) prior to electroporation (BioRad Gene Pulser Xcell). The cells were then left to 294 
recover in TAP complemented with 40-60 mM sucrose for 16 h under appropriate light and 295 
shaking conditions (typically 50 µmol photon m-² s-1 at 100 rpm) prior to plating on TAP-agar 296 
plates with adapted antibiotics. Transformation by glass-beads method followed previously 297 
published protocols
7, 64
. Briefly, after growth in TAP until 5 x 10
6
 cells/mL, cells were 298 
concentrated 30 times and 5 x 107 cells were mixed with DNA using glass beads. After 2-fold 299 
dilution with TAP, 2.5 x 107 cells were spread onto TAP agar plates containing 100 µg ml-1 300 
spectinomycin. Plates were incubated for 16 h in the dark prior to light exposition (30 µmol 301 
photon.m-2.s-1). When colony counting was performed (Figure 3a), it was 8 days after the 302 
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beginning of light. In both cases, the transformation protocol leads to insertion of a linear 303 
DNA in a random location within the nuclear genome. 304 
 305 
Design. All in silico sequence designs and analysis were performed with Serial Cloner, 306 
Benchling, SnapGene, ApE or Genome Compiler. For exogenous parts, reverse translation 307 
was performed with Serial Cloner using C. reinhardtii nuclear genome codon frequency 308 
(http://www.kazusa.or.jp/codon/cgi-bin/showcodon.cgi?species=3055). 309 
amiRNAs can be generated using DNA parts pCM0-068 and pCM0-069. Both are derived 310 
from the endogenous pre-miR1157
65
, but differ in the way in which the amiRNA specific 311 
sequence is introduced. pCM0-069/pCMM-20 is analogous to pChlamyRNA365, and a dsDNA 312 
fragment containing the amiRNA/loop/amiRNA* sequence is introduced into a SpeI site 313 
inside the miRNA precursor sequence. pCM0-068 presents two divergently oriented BpiI 314 
sites, allowing the cloning of the dsDNA fragment by Golden Gate. In this last case, the 315 
dsDNA fragment is formed by the annealing of two oligos with the following sequence: 1) 316 
sense oligo (5' AGTA-(MIRNA*SEQ)-317 
TCTCGCTGATCGGCACCATGGGGGTGGTGGTGATCAGCGCTA-(MIRNA SEQ)-T 3'), 2) anti-sense 318 
oligo (5'CAGT-A-(rev com MIRNA SEQ)- 319 
TAGCGCTGATCACCACCACCCCCATGGTGCCGATCAGCGAGA-(rev com MIRNA*SEQ) 3’). There 320 
are online tools that help with the design of the amiRNA sequence 321 
(http://wmd3.weigelworld.org/cgi-bin/webapp.cgi). 322 
 323 
Parts repository. All sequences listed in Supplementary Table 2 were deposited in Addgene. 324 
Physical distribution of the DNA is performed through Addgene. We invite the community to 325 
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share their future parts through Addgene and/or with our consortium (contact M. Schroda) 326 
which will make them available to the community. 327 
 328 
Parts cloning. All PCR reactions were performed using the Phusion DNA polymerase, KOD 329 
Xtreme Hot Start DNA polymerase (Merck) or Q5 DNA polymerase purchased from New 330 
England Biolabs (NEB) following the manufacturer’s instructions adapted to GC-rich DNA, 331 
typically duration of hybridization and polymerization was doubled and/or GC enhancer 332 
solution was used. Molecular biology kits were purchased from Macherey-Nagel, peqLab, 333 
NEB or QIAgen (gel extraction and miniprep kits). Primers were produced by Eurofins 334 
Genomics or Sigma-Aldrich while synthesized parts were obtained from Genecust, DC 335 
Biosciences, IDTDNA or Sigma-Aldrich. 336 
 337 
MoClo Assembly Conditions. All Restriction/ligation reactions were performed using BbsI or 338 
BbsI-HF (BpiI is an isoschizomer) or BsaI-HF (NEB or ThermoFisher) together with T4 ligase 339 
(NEB) in a medium containing the NEB CutSmart buffer and 1 mM ATP (with stock of 10 mM 340 
solubilized in 0.1 M Tris-HCl, pH 7.9). Typical ratio between destination plasmid (100 fmol) 341 
and entry plasmid/parts was 1:2. To facilitate handling of the kit for end-users, we provide 342 
detailed protocols and reaction mix calculators for each type of assembly: level 0 for parts 343 
(Supplementary Table 6), level 1 for modules (Supplementary Table 7) and level M for 344 
devices (Supplementary Table 8). 345 
 346 
Quality Control of generated DNAs. All plasmids were controlled by differential restriction. 347 
In addition, all level 0 plasmids were sequenced with specific primers. Sequencing was 348 
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performed by Eurofins Genomics, Source BioSciences UK, Seqlab, Macrogen, Microsynth, 349 
GATC Biotech or Core Facility (CeBiTec, Bielefeld University). 350 
 351 
NanoLuc activity determination. Reagents were purchased from Promega (ref. N1110) and 352 
activity was determined as previously described39. For screening, C. reinhardtii colonies were 353 
transferred into a 96-well plate containing 100 µL of TAP in each well. After gentle 354 
resuspension, 50 µL was transferred into a solid white 96-well plate to which 50 µL of Nano-355 
Glo substrate diluted in the provided buffer (2% V/V) was added and gently mixed by 356 
pipetting. Luminescence was measured at 460 nm with a CLARIOstar plate reader (BMG 357 
Labtech). For promoter/terminator combination assessment experiment (Figure 3c), all C. 358 
reinhardtii colonies from a transformation event were pooled and resuspended in TE buffer 359 
(50 mM Tris-HCl pH 7.9, 1 mM EDTA) complemented with anti-protease (1 tablet per 50 mL, 360 
Sigma-Aldrich: S8830). The cells were lysed by vortexing 10 seconds twice in the presence of 361 
glass beads (about 1:5 ratio beads/cells V/V) prior to two centrifugations (20000 g for 10 min 362 
at 4°C) to clarify the supernatant. The protein concentration was then determined using 363 
Bradford reagent with a Bovine Serum Albumin standard curve and the concentration was 364 
standardized to 0.5 g/L. The activity was determined in a 96-well plate in a final volume of 365 
50 µL (1:1 with nano-Glo resuspended in provided lysis buffer) per well. NanoLuc activity was 366 
determined on 6 different increasing protein quantities (0.1 to 2.5 µg) for each assay, 367 
allowing to assess linearity of the signal.  368 
 369 
Absorbance measurement of cultures growing in microtiter plates 370 
Growth in microtiter plates was determined by measuring the optical density of each well at 371 
730 nm. Microtiter plates containing 180-200 μL culture were incubated under constant light 372 
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(125 µmol photon.m-2.s-1) at 25°C and 40 rpm orbital shaking. For density determination, 373 
cultures were resuspended by pipetting and 100 µL of cell suspension was transferred to a 374 
new microtiter plate containing 50 µL TAP 0.03% Tween-20. Optical density of each well was 375 
determined at 730 nm in a CLARIOstar plate reader (BMG Labtech). Plates were shaken for 376 
6-10 sec at 600 rpm before measurement. 377 
 378 
RNA extraction and miRNA-mediated cleavage mapping 379 
RNA isolation was carried out as previously described49 (a detailed protocol can be found at 380 
http://www.plantsci.cam.ac.uk/research/davidbaulcombe/methods/downloads/smallrna.pd381 
f/view), with the following modifications: Cells were centrifuged and resuspended in 0.25 mL 382 
of water and mixed with 0.25 mL Lysis buffer (50 mM Tris-HCl pH 8.0, 200 mM NaCl, 50 mM 383 
EDTA, 2% SDS, 1 mg/mL proteinase K). Lysis buffer was incubated at 50°C for 5 min prior 384 
mixing with cells. Cell suspension was then incubated at 25°C for 20 min. Finally, 2 mL of 385 
PureZol (Biorad) was added and samples were snap-frozen. RNA quality was assessed in gel 386 
and quantified in Nanodrop (ThermoFisher scientific). 387 
miRNA cleavage site determination was performed as previously described66. Briefly, 10 µg 388 
of total RNA was ligated with an RNA oligo (5' CGACUGGAGCACGAGGACACUGACAUGGAC 389 
UGAAGGAGUAGAAA 3') using T4 RNA ligase for 1 h at 37°C. RNA was extracted with 390 
phenol:chloform and precipitated with ethanol and sodium acetate. The precipitated RNA 391 
was retrotranscribed into cDNA by SuperScript IV reverse transcriptase (ThermoFisher 392 
scientific), using random hexamers and following manufacturer’s recommendations. Two µL 393 
of the cDNA was used as template of a PCR using primers FJN456 (5’- 394 
CGACTGGAGCACGAGGACACTGA) and FJN495 (5’- TGGGGTAGGGGTGGGGGCCAG). Two µL of 395 
this PCR was used as template of a second PCR with primers FJN457 (5’- 396 
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GGACACTGACATGGACTGAAGGAGTA) and FJN496 (5’- TGACCCAGTCGCGGATGGCCT). PCR 397 
was resolved in a 2% agarose gel and the specific band was isolated from the gel and cloned 398 
into pGEM-T easy (Promega) for sequencing. 399 
 400 
Immuno-blotting. Chlamydomonas cells expressing FKB12 fusion proteins from liquid 401 
cultures were collected by centrifugation 4000 g for 5 min at room temperature (RT), 402 
washed in 50 mM Tris-HCl pH 7.5, and resuspended in a minimal volume of the same 403 
solution. Cells were lysed by two cycles of slow freezing to -80°C followed by thawing at RT. 404 
The soluble cell extract was separated from the insoluble fraction by centrifugation (15000 g 405 
for 20 min at 4°C). Total protein extracts (15 µg) were then subjected to 15% SDS-PAGE. 406 
mCherry-expressing cells were harvested at 3500 rpm for 2 min (4 °C) and resuspended in 407 
60 µL of DTT-carbonate buffer (0.1 M DTT, 0.1 M Na2CO3). After freezing at -20 °C and 408 
thawing, 55 µL of SDS-Sucrose buffer were added (5 % SDS, 30 % sucrose). Samples were 409 
then boiled for 45 s at 95 °C, followed by 2 min incubation on ice and 13000 g centrifugation 410 
for 2 min at RT. Protein extracts corresponding to 2 µg of Chlorophyll were then separated 411 
using 12% SDS-PAGE. 412 
For immunoblot analyses, proteins were then transferred to nitrocellulose membranes (Bio-413 
Rad, 162-0115 or Amersham Protran). After blocking with 3 to 5% low-fat Milk in PBS for 1 h 414 
at RT, membranes were incubated with primary antibody in 5% low-fat Milk in PBS for 16 h 415 
at 4°C. After 4 washes in PBS - 0.1% tween-20 (TPBS), the membranes were incubated with 416 
secondary antibody in 5% low-fat Milk in PBS for 1 h at RT, and subsequently washed 4 time 417 
in TPBS prior to chemi-luminescence revelation using ECL. Primary antibodies used were 418 
anti-FKBP12 
52
 (1/5000 dilution; secondary was anti-rabbit 1/10000), anti-FLAG (Sigma-419 
Aldrich F1804, 1/5000 dilution; secondary was anti-mouse 1/5000), anti-STREP (IBA, Catalog 420 
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N. 2-1509-001, 1/5000 dilution; conjugated to HRP), anti-cMYC (Sigma-Aldrich M4439, 421 
1/2500 dilution; secondary was anti-mouse 1/5000), anti-HA (Sigma-Aldrich H9658, 1/5000 422 
dilution; secondary was anti-mouse 1/2500) and anti-PRPL1
67
. For mCherry serum, rabbits 423 
were immunized against purified full-length mCherry protein containing an N-terminal His6-424 
tag. 425 
 426 
Microscopy. For mCherry experiments (Figure 6b-e), images were taken at 100x 427 
magnification with a BX53F microscope (Olympus). Fluorescence images for the detection of 428 
mCherry were taken using a TRITC filter. For other fluorescent proteins (Figure 6f-h), 429 
microscopy was performed as previously described 7, 68. 430 
 431 
Accession numbers. All parts accession numbers and the corresponding references are listed 432 
in Supplementary Table 2. 433 
 434 
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 454 
Abbreviation. 455 
MoClo: Modular Cloning, TU: Transcriptional Unit, RBCS2: Ribulose Bisphosphate 456 
Carboxylase oxygenase Small subunit 2,HSP70: Heat Shock Protein 70, AR: HSP70A/RBCS2, 457 
TUB2: Tubulin 2, PSAD: Photosystem I reaction center subunit II, HET: 4-methyl-5-(2-458 
hydroxyethyl) thiazole, HMP: 4-amino-5-hydroxymethyl-2-methylpyrimidine, amiRNA: 459 
artificial micro RNA, TAP: Tris Acetate Phosphate 460 
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 706 
Figure 1. Overview of the Chlamydomonas MoClo toolkit. 707 
(a) Type and position of parts used following the Plant MoClo Syntax
30
. Symbols correspond to the SBOL2.0 708 
visual
69
 representation described in b. Each of the 11 fusion sites defining a part position is represented with a 709 
color and a number. Positions presented are representative of the whole set of each part type. Parts in 710 
italicized letters are non-transcribed, parts in regular letters are transcribed and parts in bold letters are 711 
transcribed and translated. 712 
(b) Table summarizing unique and total gene parts available. The SBOL2.0 symbols are indicated for each type. 713 
When the SBOL2.0 standard was not existing for a part type, the symbol proposed before
28
 was used, or 714 
defined here.  715 
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 716 
Figure 2. List of parts in function of their type and assembly position.  717 
(a) Plant MoClo syntax
30
 indicating the color code for fusion sites used in this figure.  718 
(b) All parts in the Chlamydomonas MoClo kit are classified primarily by their function, indicated by 719 
SBOL2.0 visual code69 as in Fig. 1 (from left to right: promoters, promoter+5’UTR, 5’UTR, introns, 720 
antibiotic resistance genes, reporter genes, artificial microRNA, immunological and purification tags, 721 
2A peptide, and 3’UTR+terminators). Colored stripes on the left and right sides of each box represent 722 
the fusion sites in 5’ and 3’ of the position, respectively, and follow the color code on top. AR and A’R 723 
stand for HSP70A/RBCS2 and HSP70A467/RBCS2, respectively36. A star (*) indicates that the part 724 
contains extra restriction sites as in pOpt vectors68 while the same part unmarked does not. An (i) 725 
indicates the presence of an intron within the part (cf. Supplementary Table 2). For amiRNA (amiR) 726 
backbones, b and s mean that BpiI and SpeI site are within the backbone for amiR cloning, 727 
respectively, while M and sc mean that the target amiR sequence for MAA7 and the control 728 
scrambled sequence were introduced into the miR1157 backbone, respectively (cf. Fig. 4). mSTOP 729 
stands for multi-STOP.  730 
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 731 
Figure 3. Constitutive promoters and reporter genes. 732 
(a) Average number of spectinomycin resistant colonies after transformation of UVM4 cells (mean ± 733 
SD, N=11) for the three modules (pCM1-3, where pCM stands for plasmid Chlamydomonas Moclo). 734 
Representative transformation plates are shown. 735 
(b) Linearity of NanoLuc activity as a function of cell number. NanoLuc activity for 4 independent 736 
clones transformed with the pCMM-1 device (pCMM-1.X), one non-expressing clone (NC) and the 737 
recipient strain (CC-4425 noted as control) are presented (N=3, mean ± SEM). Linear regression and 738 
correlation coefficient (R²) are shown. The NC and control are shown in the inset on a different scale. 739 
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(c) Average NanoLuc activity of D66 (CC-4425) cells transformed with 4 devices (pCMM-1 to 4) 740 
harboring promoter/terminator combinations to drive NanoLuc expression coupled to a 741 
paromomycin resistance module (represented as P
R
, left, Supplementary Fig. 2). Luminescence levels 742 
are represented as mean ± SEM (average of a total of more than 400 clones from 3 biological 743 
replicates). The negative and positive controls are the recipient strain and the pCMM-1.9 strain 744 
(shown in b), respectively. 745 
a,c *p<0.05; **p< 0.01 assessed by Student’s t-test, SBOL2.0
69
 visual of module designs are shown 746 
above the devices.  747 
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 748 
Figure 4. Control of gene expression. 749 
(a) Control of gene expression by the nitrogen source. Zeocin resistant colonies (conferred by Ble(i)-GFP) 750 
selected after transformation of CC-1690 cells with each of the two represented modules (“1-8” for pCM1-8 751 
and “1-9” for pCM1-9) were grown in TAP-nitrogen ± zeocin (15 µg/mL) supplemented with either 7.5 mM 752 
(NH4)Cl (ammonium, blue) or 4 mM KNO3 (nitrate, black) and their growth was followed (Absorbance at 730 753 
nm). The plot shows the ratio between the growth in the presence and absence of zeocin (C is the non-754 
transformed CC-1690 strain). The right panel shows cells grown in similar conditions but on solid media. Results 755 
presented (N=16 for control CC-1690 and N=86 for each other conditions) correspond to one out of three 756 
independent transformations (for the other two, see Supplementary Fig. 3). 757 
(b) Control of gene expression by vitamin B12. Conditional complementation of nac2-26 cells with the pCM1-10 758 
module expressing NAC2 under PMETE control. Complemented strains were selected for photoautotrophic 759 
growth on solid minimal medium and the cells were grown in liquid minimal medium supplemented with the 760 
indicated amount of vitamin B12. Data are mean ± SD (N=3). 761 
(c) Control of gene expression by vitamin B1. Average growth (absorbance at 730 nm after 7 days of growth, 762 
N=40) of UVM4 cells transformed with the pCM1-11 module designed to express constitutively Ble(i)-GFP 763 
transcripts containing the THI4 riboswitch in the 5’UTR. After culture in TAP, the cells were transferred to 764 
TAP+zeocin (10 µg/mL) supplemented with 10 µM thiamine (Thi), 10 µM 4-methyl-5-(2-hydroxyethyl) thiazole 765 
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(HET) or 10 µM 4-amino-5-hydroxymethyl-2-methylpyrimidine (HMP) or not (control). The chemical structure 766 
of Thi is represented on the right and the HET and HMP moieties are indicated (See also Supplementary Fig. 3).  767 
(d) Targeted gene knockdown with artificial miRNA. Paromomycin resistant cells selected after transformation 768 
of CC-1690 cells by each of the two represented devices (pCMM-5 and pCMM-6), carrying an amiRNA cloned 769 
with BpiI and directed against MAA7 (MAA7-amiRb) or a random sequence (’scrambled’: sc-amiRb), were 770 
grown in the absence (denoted (-)) or presence of 5'-fluoroindole (+5’-FI) (left panel). C indicates non-771 
transformed cells. Clones resistant to 5'FI were analyzed by a modified 5'-RACE assay. A specific 173 bp PCR 772 
band (black arrowhead) was amplified only from the 5'-FI resistant transformants and not from ones expressing 773 
the amiRNA with scrambled sequence (middle panel and Supplementary Fig. 3). Sequencing revealed that the 774 
most frequent cleavage occurred at positions opposed to positions 10 and 11 of the amiRNA (right panel, black 775 
arrowhead). P
R
 represents the paromomycin resistance module (pCM1-27, Supplementary Fig. 2a). 776 
a, c The box and whisker plots show the 10
th
 (lower whisker), 25
th
 (base of box), 75
th
 (top of box) and 90
th
 (top 777 
whisker) percentiles. The line within the box is the median, the dashed red line is the mean. Outliers are 778 
plotted as individual data points. 779 
  780 
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 781 
Figure 5. Design, build and test of five fusion tags 782 
(a) Phenotype of recipient (WT) and ΔFKBP12 (rap2) strains in the presence (Rap) or absence (-) of 1 µM 783 
rapamycin. 784 
(b) Molecular mechanism underlying the rap2 phenotype. Target Of Rapamycin (TOR) is inhibited by rapamycin 785 
only in the presence of FKBP12 (mutated in rap2). Upon formation of the tripartite TOR/FKBP12/rapamycin 786 
complex, TOR is inhibited and growth is arrested
52
. 787 
(c) SBOL2.0 visual
69
 of module designs for functional complementation of rap2. 788 
(d-h) Phenotype in the presence (Rap) or absence (-) of 1 µM rapamycin and detection of tagged proteins in 789 
soluble extracts by immunoblotting with antibodies against either FKBP12 (αFKBP12) or the appropriate tag 790 
(indicated within each panel). Each device is indicated in the upper part of the panel. CBB: Coomassie Brilliant 791 
Blue staining of a duplicate gel loaded with the same samples and shown as loading control. 792 
(i) Purification through ion-metal affinity chromatography (IMAC) of 6His-FKBP12 expressed from the same 793 
device as in h. 794 
P
R
 represents the paromomycin resistance module (pCM1-27, Supplementary Fig. 2a). rap2 cells transformed 795 
with pCMM-X are indicated as M-X in each panel. Data are representative of 3 biological replicates. 796 
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 797 
Figure 6. Targeting reporter genes to different subcellular compartments. 798 
(a) SBOL2.0
69
 visual syntax for modules used. 799 
(b) Visible light (“DIC”) and fluorescence signal (“mCherry”) of the UVM4 recipient strain used as control (“C”) 800 
for panels c-e. 801 
(c-e) mCherry targeting to the (c) cytosol with no transit peptide, (d) chloroplast with CTP USPA (Chloroplast 802 
Transit Peptide of Universal Stress Protein A) or (e) mitochondria with MTP H70C (Mitochondrial Transit 803 
Peptide of HSP70C) in UVM4 cells transformed with the indicated devices (pCMM-12 to 14). In each panel, an 804 
anti-mCherry immunoblot analysis of transformants is shown. Note that the anti-mCherry antibody cross-reacts 805 
with a protein of similar size present in control cells (C). An anti-PRPL1 immunoblot is shown as loading control. 806 
The transformant strain number indicated in red corresponds to the images (bars are 10 µm) presented on the 807 
right. 808 
(f-h) Fluorescent marking of (f) microbodies with mVenus-CrMSPTS1 (Malate Synthase PTS1-like sequence), 809 
cytosol with Clover or the nucleus with mVenus-SV40 (Simian Virus 40 nuclear localization signal), (g) the 810 
chloroplast with CTP PSAD-mCerulean (Chloroplast Transit Peptide of PSAD), (h) mitochondria with MTP ATPA-811 
mRuby2 (Mitochondrial Transit Peptide of ATPA) after transformation of UVM4 cells with the indicated devices 812 
(pCMM-15 to 19). Images of representative transformants are grouped with the corresponding control image 813 
(recipient strain) according to the filter used. pCMM-19a and pCMM-19b show two images taken on different 814 
z-axis on the same cell. “Chloro” refers to chlorophyll autofluorescence. The Scale bars represent 2 µm. 815 
S
R
 and P
R
 represent respectively modules conferring resistance to spectinomycin (S
R
=pCM1-1, Fig. 3a and 816 
Supplementary Fig. 2a) and paromomycin (P
R
=pCM1-27, Supplementary Fig. 2a). 817 
Page 35 of 34
ACS Paragon Plus Environment
ACS Synthetic Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
